Fig. 5
From: Mesoporous silica nanotechnology: promising advances in augmenting cancer theranostics
Graphical representation of a drug-loaded theranostic MSN platform designed to have light-based triggers for therapeutic responses
Fig. 5 | Cancer Nanotechnology